Both AChE and BChE enzymes are responsible for lowering the level of acetylcholine in the synaptic cleft of the brain leading to neurodegenerative disorders—namely, Alzheimer’s disease, Parkinson disease, and cognitive problems. This evidence concerns the gene BCHE and early-onset autosomal dominant Alzheimer disease.